Antitumoral use of cabazitaxel | Patent Number 08927592

US 08927592 B2
Application Number13456720
Publication NumberUS 20120301425 A1
Pendency2 years, 8 months, 15 days
Filled DateApr 26, 2012
Priority DateOct 29, 2009
Publication DateNov 29, 2012
Expiration DateOct 28, 2029
Inventor/ApplicantsSunil Gupta
Sunil GUPTA
ExaminesANDERSON, JAMES D
Art Unit1629
Technology Center1600
Assignments
Sanofi Mature Ip
Current
Aventis Holdings Inc. SanofiSanofi
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.